165 related articles for article (PubMed ID: 11322635)
1. Enhanced ocular hypotensive response to timolol in rabbits with prior dexamethasone treatment.
Schwartz B; Rom ME
J Ocul Pharmacol Ther; 2001 Feb; 17(1):27-33. PubMed ID: 11322635
[TBL] [Abstract][Full Text] [Related]
2. Enhanced ocular hypotensive response to epinephrine in rabbits with prior dexamethasone treatment.
Rom ME; Schwartz B; Ungricht AL; Lee W
J Ocul Pharmacol Ther; 1997 Aug; 13(4):313-20. PubMed ID: 9261767
[TBL] [Abstract][Full Text] [Related]
3. Enhanced acute ocular hypotensive response to timolol with dexamethasone treatment.
Rom M; Schwartz B; Bealka N
J Glaucoma; 1997 Apr; 6(2):111-6. PubMed ID: 9098819
[TBL] [Abstract][Full Text] [Related]
4. Dose response of dexamethasone for the enhanced ocular hypotensive response to epinephrine in rabbits with prior dexamethasone treatment.
Schwartz B; Rom ME; Bealka N; Qi Y
J Ocul Pharmacol Ther; 2002 Apr; 18(2):133-9. PubMed ID: 12002667
[TBL] [Abstract][Full Text] [Related]
5. Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits: significance for combination therapy in glaucoma.
Crooke A; Huete-Toral F; Martínez-Águila A; Martín-Gil A; Pintor J
J Pharmacol Exp Ther; 2013 Jul; 346(1):138-45. PubMed ID: 23591996
[TBL] [Abstract][Full Text] [Related]
6. A complex interaction between topical verapamil and timolol on intraocular pressure in conscious rabbits.
Santafé J; Martínez de Ibarreta MJ; Segarra J; Melena J; Garrido M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):198-204. PubMed ID: 8857598
[TBL] [Abstract][Full Text] [Related]
7. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
[TBL] [Abstract][Full Text] [Related]
8. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
[TBL] [Abstract][Full Text] [Related]
9. A comparison of trabeculectomy with topically applied timolol in a rabbit ocular hypertension model.
Lu DW; Chiang CH; Shang ST; Chou PI
J Ocul Pharmacol Ther; 1998 Aug; 14(4):323-9. PubMed ID: 9715435
[TBL] [Abstract][Full Text] [Related]
10. Enhanced ocular hypotensive response to epinephrine with prior dexamethasone treatment.
Bealka N; Schwartz B
Arch Ophthalmol; 1991 Mar; 109(3):346-8. PubMed ID: 2003792
[TBL] [Abstract][Full Text] [Related]
11. Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits.
Pate DW; Järvinen K; Urtti A; Jarho P; Järvinen T
Curr Eye Res; 1995 Sep; 14(9):791-7. PubMed ID: 8529418
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and intraocular pressure lowering effect of timolol preparations in rabbit eyes.
Chiang CH; Ho JI; Chen JL
J Ocul Pharmacol Ther; 1996; 12(4):471-80. PubMed ID: 8951683
[TBL] [Abstract][Full Text] [Related]
13. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
Sonty S; Mundorf TK; Stewart JA; Stewart WC
Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
[TBL] [Abstract][Full Text] [Related]
14. Physicochemical properties and in vivo assessment of timolol-loaded poly(D,L-lactide-co-glycolide) films for long-term intraocular pressure lowering effects.
Huang SF; Chen JL; Yeh MK; Chiang CH
J Ocul Pharmacol Ther; 2005 Dec; 21(6):445-53. PubMed ID: 16386086
[TBL] [Abstract][Full Text] [Related]
15. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
Manni G; Denis P; Chew P; Sharpe ED; Orengo-Nania S; Coote MA; Laganovska G; Volksone L; Zeyen T; Filatori I; James J; Aung T
J Glaucoma; 2009; 18(4):293-300. PubMed ID: 19365194
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic and systemic side effects of ocular beta-adrenergic antagonists in anesthetized dogs.
Svec AL; Strosberg AM
Invest Ophthalmol Vis Sci; 1986 Mar; 27(3):401-5. PubMed ID: 2869005
[TBL] [Abstract][Full Text] [Related]
17. Timolol. A new drug for management of chronic simple glaucoma.
Radius RL; Diamond GR; Pollack IP; Langham ME
Arch Ophthalmol; 1978 Jun; 96(6):1003-8. PubMed ID: 655936
[TBL] [Abstract][Full Text] [Related]
18. The extended ocular hypotensive effect of positive liposomal cholesterol bound timolol maleate in glaucomatous rabbits.
Shafaa MW; Sabra NM; Fouad RA
Biopharm Drug Dispos; 2011 Dec; 32(9):507-17. PubMed ID: 22028305
[TBL] [Abstract][Full Text] [Related]
19. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost.
Miura K; Ito K; Okawa C; Sugimoto K; Matsunaga K; Uji Y
J Glaucoma; 2008; 17(3):233-7. PubMed ID: 18414111
[TBL] [Abstract][Full Text] [Related]
20. The effects of separate and combined topical treatment with timolol maleate and trifluormethazolamide on the intraocular pressure in normal rabbits.
Bar-Ilan A
Curr Eye Res; 1984 Nov; 3(11):1305-12. PubMed ID: 6542484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
